Yuan Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuan Liu has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Lu Wang
Department of Clinical Laboratory, The General Hospital of Western Theater Command, Chengdu, China
8 shared publicationsYuanqing Qu
Department of Clinical Laboratory, The General Hospital of Western Theater Command, Chengdu, China
8 shared publicationsZonghai Hu
Department of Clinical Laboratory, The General Hospital of Western Theater Command, Chengdu, China
5 shared publicationsZiying Zou
Clinical Laboratory, The General Hospital of Western Theater Command, Chengdu, China
4 shared publications- Jie Xiong
Clinical Laboratory, General Hospital of Chengdu Military Region of PLA, Chengdu, China
3 shared publications Lu Liu
Department of Clinical Laboratory, The General Hospital of Western Theater Command, Chengdu, China
3 shared publications
Latest Publications
- Open Access
- 28 May 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1842447
Chromoblastomycosis caused by Fonsecaea pedrosoi: a case report and literature review
Fonsecaea pedrosoi , a pathogenic fungus within the order Chaetomycosis of the family Dematiaceae, is the primary causative agent of Chromoblastomycosis (CBM). Its clinical manifestations are diverse and lack specificity, often being confused with other skin diseases, which can easily lead to misdiagnosis or missed diagnosis. This article reports a case of a 36-year-old immunocompromised female with chronic infection caused by F. pedrosoi following minor trauma to the right knee. The patient presented with plaque-like hyperplasia, pruritus, desquamation, and suppuration of the local skin over the right knee, with persistent and refractory clinical course. The definite diagnosis was ultimately established through mycological, histopathological, and molecular biological examinations, followed by appropriate therapeutic intervention. This case indicates that chromoblastomycosis is prone to missed or delayed diagnosis due to its atypical clinical manifestations. Moreover, immunocompromised patients are more likely to experience prolonged disease course and slow recovery, highlighting the critical importance of accurate diagnosis and rational selection of treatment regimens. Combined with a literature review, it analyzes the clinical characteristics and key points in diagnosis and treatment of the disease, explores approaches to strengthen the awareness of clinical monitoring, and aims to improve the overall public health awareness of the disease.
- 28 May 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1842447
Open AccessChromoblastomycosis caused by Fonsecaea pedrosoi: a case report and literature review
Fonsecaea pedrosoi , a pathogenic fungus within the order Chaetomycosis of the family Dematiaceae, is the primary causative agent of Chromoblastomycosis (CBM). Its clinical manifestations are diverse and lack specificity, often being confused with other skin diseases, which can easily lead to misdiagnosis or missed diagnosis. This article reports a case of a 36-year-old immunocompromised female with chronic infection caused by F. pedrosoi following minor trauma to the right knee. The patient presented with plaque-like hyperplasia, pruritus, desquamation, and suppuration of the local skin over the right knee, with persistent and refractory clinical course. The definite diagnosis was ultimately established through mycological, histopathological, and molecular biological examinations, followed by appropriate therapeutic intervention. This case indicates that chromoblastomycosis is prone to missed or delayed diagnosis due to its atypical clinical manifestations. Moreover, immunocompromised patients are more likely to experience prolonged disease course and slow recovery, highlighting the critical importance of accurate diagnosis and rational selection of treatment regimens. Combined with a literature review, it analyzes the clinical characteristics and key points in diagnosis and treatment of the disease, explores approaches to strengthen the awareness of clinical monitoring, and aims to improve the overall public health awareness of the disease.
- Open Access
- 30 March 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1793472
Case Report: A case of severe infection caused by Clostridium septicum: a literature review
Clostridium septicum , an anaerobic spore-forming Gram-positive bacillus, is a rare opportunistic pathogen that causes severe infections with rapid progression and high mortality. Trauma with unmanaged contaminated wounds is a major risk factor, and atypical presentations such as tetanus-like neuromuscular symptoms often lead to misdiagnosis. Herein, we report a 72-year-old male farmer with C. septicum and Enterobacter cloacae co-infection following a traumatic toe laceration, presenting with trismus, limited mouth opening, and right toe gangrene. This case highlights the diagnostic challenges of C. septicum infection mimicking tetanus and the importance of comprehensive etiological testing and multidisciplinary management. We also review relevant literature to provide insights for clinical practice.
- 30 March 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1793472
Open AccessCase Report: A case of severe infection caused by Clostridium septicum: a literature review
Clostridium septicum , an anaerobic spore-forming Gram-positive bacillus, is a rare opportunistic pathogen that causes severe infections with rapid progression and high mortality. Trauma with unmanaged contaminated wounds is a major risk factor, and atypical presentations such as tetanus-like neuromuscular symptoms often lead to misdiagnosis. Herein, we report a 72-year-old male farmer with C. septicum and Enterobacter cloacae co-infection following a traumatic toe laceration, presenting with trismus, limited mouth opening, and right toe gangrene. This case highlights the diagnostic challenges of C. septicum infection mimicking tetanus and the importance of comprehensive etiological testing and multidisciplinary management. We also review relevant literature to provide insights for clinical practice.
- 18 March 2026
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 310, 118780
Unlocking the potential of TNF: From biologic agents to small-molecule inhibitors
- 18 March 2026
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 310, 118780
Unlocking the potential of TNF: From biologic agents to small-molecule inhibitors
- Open Access
- 30 October 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1671968
Case Report: First pulmonary infection caused by Mycobacterium colombiense in a non-immunosuppressed host with bronchiectasis: diagnosis facilitated by synergistic mNGS and culture
Mycobacterium colombiense , a rare slow-growing mycobacterium within the Mycobacterium avium complex (MAC), causes disseminated disease almost exclusively in immunocompromised hosts, with no prior reports of localized pulmonary infection in non-immunosuppressed individuals. A 47-year-old non-immunosuppressed male with bronchiectasis presented with progressive cough, night sweats, and fatigue. Computed tomography (CT) revealed bronchiectasis with nodules in the right middle and lower lobes. Empirical β-lactam therapy failed, and conventional bronchoalveolar lavage fluid (BALF) tests (smears, cultures, PCR) yielded no pathogens at 48 h. Although metagenomic next-generation sequencing (mNGS) of BALF detected a low number of M. colombiense sequences (eight reads), definitive confirmation was achieved through extended culture, which is considered the gold standard for the diagnosis of nontuberculous mycobacteria. This culture revealed acid-fast bacilli within 12 days (160 CFU), confirming the presence of viable M. colombiense . Subsequent mNGS of the isolated colonies further confirmed the species identity with high sequence reads (25,787 reads). Guideline-based triple therapy (guided by drug susceptibility testing and guidelines) with clarithromycin, rifampicin, and ethambutol achieved significant radiographic resolution at 24 weeks. This case demonstrates that M. colombiense pulmonary infection is diagnostically elusive and mimics non-specific respiratory syndromes. It defines the clinical features of this pathogen in non-immunosuppressed hosts and highlights the need for heightened surveillance for nontuberculous mycobacteria (NTM) in bronchiectasis patients, given the likelihood of underdiagnosis.
- 30 October 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1671968
Open AccessCase Report: First pulmonary infection caused by Mycobacterium colombiense in a non-immunosuppressed host with bronchiectasis: diagnosis facilitated by synergistic mNGS and culture
Mycobacterium colombiense , a rare slow-growing mycobacterium within the Mycobacterium avium complex (MAC), causes disseminated disease almost exclusively in immunocompromised hosts, with no prior reports of localized pulmonary infection in non-immunosuppressed individuals. A 47-year-old non-immunosuppressed male with bronchiectasis presented with progressive cough, night sweats, and fatigue. Computed tomography (CT) revealed bronchiectasis with nodules in the right middle and lower lobes. Empirical β-lactam therapy failed, and conventional bronchoalveolar lavage fluid (BALF) tests (smears, cultures, PCR) yielded no pathogens at 48 h. Although metagenomic next-generation sequencing (mNGS) of BALF detected a low number of M. colombiense sequences (eight reads), definitive confirmation was achieved through extended culture, which is considered the gold standard for the diagnosis of nontuberculous mycobacteria. This culture revealed acid-fast bacilli within 12 days (160 CFU), confirming the presence of viable M. colombiense . Subsequent mNGS of the isolated colonies further confirmed the species identity with high sequence reads (25,787 reads). Guideline-based triple therapy (guided by drug susceptibility testing and guidelines) with clarithromycin, rifampicin, and ethambutol achieved significant radiographic resolution at 24 weeks. This case demonstrates that M. colombiense pulmonary infection is diagnostically elusive and mimics non-specific respiratory syndromes. It defines the clinical features of this pathogen in non-immunosuppressed hosts and highlights the need for heightened surveillance for nontuberculous mycobacteria (NTM) in bronchiectasis patients, given the likelihood of underdiagnosis.
- Open Access
- 13 October 2025
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1633833
Concurrent classical and hypervirulent Klebsiella pneumoniae infection in distinct host niches revealed by a rapid nanopore whole-genome and plasmid sequencing method
Introduction: This study reports a rare case of dual-strain Klebsiella pneumoniae infection involving genetically distinct isolates from the lung and eye of a previously immunocompetent patient.Methods: A rapid nanopore sequencing workflow on the Gseq-500 platform was used for whole-genome and plasmid sequencing. Comparative genomic and phylogenetic analyses assessed isolate relatedness and identified virulence and resistance determinants.Results: The lung isolate (KP-L) belonged to the hypervirulent ST23/KL1 lineage and carried a large non-conjugative plasmid encoding rmpA, rmpA2, iuc, iro, and peg-344, together with chromosomal yersiniabactin. In contrast, the eye isolate (KP-E) was a classical ST133/KL116 strain lacking known hypervirulence markers but harboring plasmids encoding heavy-metal resistance genes. Despite the absence of hypervirulence factors, KP-E caused severe endophthalmitis requiring enucleation, underscoring the pathogenic potential of classical strains in immune-privileged sites. Comparative genomic and phylogenetic analyses confirmed that the two isolates were not clonally related.Discussion: We propose a plausible infection trajectory involving initial hypervirulent K. pneumoniae (hvKp) dissemination followed by niche-specific replacement by Classical K. pneumoniae (cKp) under antibiotic pressure. This case underscores that severe infections can arise from genetically “low-virulence” strains in certain host environments. Comprehensive genomic surveillance and aggressive clinical management strategies remain crucial for improving patient prognosis and understanding pathogen adaptation mechanisms within host niches.
- 13 October 2025
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1633833
Open AccessConcurrent classical and hypervirulent Klebsiella pneumoniae infection in distinct host niches revealed by a rapid nanopore whole-genome and plasmid sequencing method
Introduction: This study reports a rare case of dual-strain Klebsiella pneumoniae infection involving genetically distinct isolates from the lung and eye of a previously immunocompetent patient.Methods: A rapid nanopore sequencing workflow on the Gseq-500 platform was used for whole-genome and plasmid sequencing. Comparative genomic and phylogenetic analyses assessed isolate relatedness and identified virulence and resistance determinants.Results: The lung isolate (KP-L) belonged to the hypervirulent ST23/KL1 lineage and carried a large non-conjugative plasmid encoding rmpA, rmpA2, iuc, iro, and peg-344, together with chromosomal yersiniabactin. In contrast, the eye isolate (KP-E) was a classical ST133/KL116 strain lacking known hypervirulence markers but harboring plasmids encoding heavy-metal resistance genes. Despite the absence of hypervirulence factors, KP-E caused severe endophthalmitis requiring enucleation, underscoring the pathogenic potential of classical strains in immune-privileged sites. Comparative genomic and phylogenetic analyses confirmed that the two isolates were not clonally related.Discussion: We propose a plausible infection trajectory involving initial hypervirulent K. pneumoniae (hvKp) dissemination followed by niche-specific replacement by Classical K. pneumoniae (cKp) under antibiotic pressure. This case underscores that severe infections can arise from genetically “low-virulence” strains in certain host environments. Comprehensive genomic surveillance and aggressive clinical management strategies remain crucial for improving patient prognosis and understanding pathogen adaptation mechanisms within host niches.
- Open Access
- 8 April 2025
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1565345
Efficacy of Kangfuxin liquid for preventing and treating chemotherapy-induced oral mucositis: a systematic review and meta-analysis of randomized controlled trials
Objective: Chemotherapy-induced oral mucositis (CTOM) is a common side effect affecting 20%–40% of cancer patients receiving chemotherapy. Kangfuxin liquid (KFXL) has been used clinically to prevent and treat CTOM, but the evidence has not been systematically evaluated. This study aimed to evaluate the preventive and therapeutic effects of KFXL on CTOM.Methods: Nine electronic databases were searched to identify KFXL-related randomized controlled trials (RCTs) for the prevention and treatment of CTOM from inception to September 2024. The primary outcomes were incidence rate, efficacy rate and cure rate, and the secondary outcomes was healing time.Results: Twenty-one trials involving 1825 patients were included in this review. The results of our meta-analysis showed that, compared with basic oral care (BOC), KFXL significantly reduced the incidence rate of CTOM and severe CTOM (RR = 0.54, p < 0.00001; RR = 0.23, p < 0.00001, respectively), improved the efficacy rate of CTOM and severe CTOM (RR = 1.23, p = 0.0003; RR = 1.99, p = 0.05, respectively), improved the cure rate of CTOM (RR = 2.06, p = 0.0004),and accelerated the healing process (MD = −2.48, p < 0.00001). However, KFXL and other drugs have the same efficacy rate in treating CTOM and severe CTOM (RR = 1.00, p = 0.99; RR = 1.00, p = 1.00, respectively), and the same cure rate in CTOM (RR = 0.91, p = 0.39), and the same healing time (MD = −0.01, p = 1.00).Conclusion: The results suggest that KFXL may provide more benefit in the prevention and treatment for CTOM compared to BOC. Although KFXL may be a promising drug for the prevention and treatment of CTOM, the evidence is insufficient to prove its superiority over other guideline-recommended treatment.Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD42024585859, ID: CRD42024585859.
- 8 April 2025
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1565345
Open AccessEfficacy of Kangfuxin liquid for preventing and treating chemotherapy-induced oral mucositis: a systematic review and meta-analysis of randomized controlled trials
Objective: Chemotherapy-induced oral mucositis (CTOM) is a common side effect affecting 20%–40% of cancer patients receiving chemotherapy. Kangfuxin liquid (KFXL) has been used clinically to prevent and treat CTOM, but the evidence has not been systematically evaluated. This study aimed to evaluate the preventive and therapeutic effects of KFXL on CTOM.Methods: Nine electronic databases were searched to identify KFXL-related randomized controlled trials (RCTs) for the prevention and treatment of CTOM from inception to September 2024. The primary outcomes were incidence rate, efficacy rate and cure rate, and the secondary outcomes was healing time.Results: Twenty-one trials involving 1825 patients were included in this review. The results of our meta-analysis showed that, compared with basic oral care (BOC), KFXL significantly reduced the incidence rate of CTOM and severe CTOM (RR = 0.54, p < 0.00001; RR = 0.23, p < 0.00001, respectively), improved the efficacy rate of CTOM and severe CTOM (RR = 1.23, p = 0.0003; RR = 1.99, p = 0.05, respectively), improved the cure rate of CTOM (RR = 2.06, p = 0.0004),and accelerated the healing process (MD = −2.48, p < 0.00001). However, KFXL and other drugs have the same efficacy rate in treating CTOM and severe CTOM (RR = 1.00, p = 0.99; RR = 1.00, p = 1.00, respectively), and the same cure rate in CTOM (RR = 0.91, p = 0.39), and the same healing time (MD = −0.01, p = 1.00).Conclusion: The results suggest that KFXL may provide more benefit in the prevention and treatment for CTOM compared to BOC. Although KFXL may be a promising drug for the prevention and treatment of CTOM, the evidence is insufficient to prove its superiority over other guideline-recommended treatment.Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD42024585859, ID: CRD42024585859.
- Open Access
- 11 October 2024
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1440130
Case report: A case of cutaneous anthrax guided by metagenomic next-generation sequencing technology
Anthrax is an acute zoonotic infectious disease caused by Bacillus anthracis. It is categorized as a Class B (reported within 24 h of onset, including pulmonary anthrax, which is managed as a Class A infectious disease and reported within 2 h of onset) infectious disease in China. Human anthrax infection primarily occurs through direct or indirect contact with infected animals. This study reports a case of cutaneous anthrax where typical anthrax colonies were observed in conventional microbial cultures, and large Gram-positive rods with squared ends were visible under the microscope. The results from metagenomic next-generation sequencing (mNGS) suggested the presence of Bacillus anthracis. This research explores the value of combining traditional microbiology with mNGS technology for the early diagnosis and therapy of infectious diseases.
- 11 October 2024
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1440130
Open AccessCase report: A case of cutaneous anthrax guided by metagenomic next-generation sequencing technology
Anthrax is an acute zoonotic infectious disease caused by Bacillus anthracis. It is categorized as a Class B (reported within 24 h of onset, including pulmonary anthrax, which is managed as a Class A infectious disease and reported within 2 h of onset) infectious disease in China. Human anthrax infection primarily occurs through direct or indirect contact with infected animals. This study reports a case of cutaneous anthrax where typical anthrax colonies were observed in conventional microbial cultures, and large Gram-positive rods with squared ends were visible under the microscope. The results from metagenomic next-generation sequencing (mNGS) suggested the presence of Bacillus anthracis. This research explores the value of combining traditional microbiology with mNGS technology for the early diagnosis and therapy of infectious diseases.
- Open Access
- 6 October 2023
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1240436
Case report: A case of pulmonary mucormycosis caused by Rhizopus azygosporus infection complicated by type 2 diabetes mellitus
A case of pulmonary mucormycosis (PM) caused by Rhizopus azygosporus infection complicated by type 2 diabetes mellitus is reported. An adult male patient had a productive cough for more than 10 days, aggravated by blood in the sputum for 9 days. Laboratory examination confirmed that he had had type 2 diabetes mellitus and diabetic ketosis for more than 3 years, and his chest computed tomography (CT) scan showed lesions, cavities, and a small effusion in the right lower lobe. The lavage fluid was taken by bronchoscope for bacterial culture and mNGS, which indicated Rhizopus azygosporus growth. Mucormycosis was diagnosed. The patient was given amphotericin B cholesterol sulfate complex for 30 days, and his renal function was closely monitored. After that, his right lower lobe was resected. To date, the patient has recovered well.
- 6 October 2023
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1240436
Open AccessCase report: A case of pulmonary mucormycosis caused by Rhizopus azygosporus infection complicated by type 2 diabetes mellitus
A case of pulmonary mucormycosis (PM) caused by Rhizopus azygosporus infection complicated by type 2 diabetes mellitus is reported. An adult male patient had a productive cough for more than 10 days, aggravated by blood in the sputum for 9 days. Laboratory examination confirmed that he had had type 2 diabetes mellitus and diabetic ketosis for more than 3 years, and his chest computed tomography (CT) scan showed lesions, cavities, and a small effusion in the right lower lobe. The lavage fluid was taken by bronchoscope for bacterial culture and mNGS, which indicated Rhizopus azygosporus growth. Mucormycosis was diagnosed. The patient was given amphotericin B cholesterol sulfate complex for 30 days, and his renal function was closely monitored. After that, his right lower lobe was resected. To date, the patient has recovered well.
- Open Access
- 28 June 2023
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 13, 1160831
Case report: A case of ocular infection caused by Corynespora cassiicola
Objective: The aim of this study is to identify the pathogen causing ocular infection in a Chinese patient and to describe its morphological characteristics.Methods: Samples from the patient’s intraoperative pus were collected for microscopic examination and culture. Morphology and drug sensitivities of the isolated fungus were analyzed. Ribosomal DNA (rDNA) sequencing was performed and blasted in GenBank.Results: A strain of fungi was repeatedly isolated from pus samples in different types of medium. No conidia were shown when the isolate cultured on normal PDA medium, whereas pseudoseptate thick-walled conidia were shown when cultured on medium containing leaf leachate. The results of BLAST and phylogenetic trees based on internal transcribed spacer, beta-tubulin, translation elongation factor 1-alpha, and RNA polymerase II gene demonstrated that the isolated fungus was Corynespora cassiicola. Minimum inhibitory concentration results of this organism were as follows: anidulafungin, 0.06 μg/ml; amphotericin B, 0.12 μg/ml; micafungin, 0.06 μg/ml; caspofungin, 0.5 μg/ml; 5-fluorocytosine, >64 μg/ml; posaconazole, 2 μg/ml; voriconazole, 0.25 μg/ml; itraconazole, 0.5 μg/ml; fluconazole, 64 μg/ml.Conclusion: The case was infected with Corynespora cassiicola and led to eye suppurative endophthalmitis and blindness. Combined applications of morphological and molecular biology techniques facilitate accurate diagnosis of fungal infections.
- 28 June 2023
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 13, 1160831
Open AccessCase report: A case of ocular infection caused by Corynespora cassiicola
Objective: The aim of this study is to identify the pathogen causing ocular infection in a Chinese patient and to describe its morphological characteristics.Methods: Samples from the patient’s intraoperative pus were collected for microscopic examination and culture. Morphology and drug sensitivities of the isolated fungus were analyzed. Ribosomal DNA (rDNA) sequencing was performed and blasted in GenBank.Results: A strain of fungi was repeatedly isolated from pus samples in different types of medium. No conidia were shown when the isolate cultured on normal PDA medium, whereas pseudoseptate thick-walled conidia were shown when cultured on medium containing leaf leachate. The results of BLAST and phylogenetic trees based on internal transcribed spacer, beta-tubulin, translation elongation factor 1-alpha, and RNA polymerase II gene demonstrated that the isolated fungus was Corynespora cassiicola. Minimum inhibitory concentration results of this organism were as follows: anidulafungin, 0.06 μg/ml; amphotericin B, 0.12 μg/ml; micafungin, 0.06 μg/ml; caspofungin, 0.5 μg/ml; 5-fluorocytosine, >64 μg/ml; posaconazole, 2 μg/ml; voriconazole, 0.25 μg/ml; itraconazole, 0.5 μg/ml; fluconazole, 64 μg/ml.Conclusion: The case was infected with Corynespora cassiicola and led to eye suppurative endophthalmitis and blindness. Combined applications of morphological and molecular biology techniques facilitate accurate diagnosis of fungal infections.